Francesco Maria Lavino
Chief Executive Officer at F2G Ltd.
Profile
Francesco Maria Lavino is currently the Chief Executive Officer & Director at F2G Ltd.
and the President & Director at F2g Inc. He previously worked as the Executive Director at Merck & Co., Inc. from 2011 to 2013, the Vice President-International Marketing at Cubist Pharmaceuticals LLC from 2013 to 2015, and the Associate Vice President at Merck & Co., Inc. from 2015 to 2017.
He also served as the Chief Commercial Officer at Nabriva Therapeutics Plc.
Lavino received his undergraduate degree from Università degli Studi di Napoli Federico II and his MBA from SDA Bocconi School of Management.
Francesco Maria Lavino active positions
| Companies | Position | Start |
|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Chief Executive Officer | 12/04/2021 |
| F2g Inc. | President | - |
Former positions of Francesco Maria Lavino
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/07/2017 |
| CUBIST PHARMACEUTICALS INC | Sales & Marketing | 01/09/2015 |
| MERCK & CO., INC. | Director/Board Member | 01/11/2013 |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | - |
Training of Francesco Maria Lavino
| Università degli Studi di Napoli Federico II | Undergraduate Degree |
| SDA Bocconi School of Management | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
| F2g Inc. |
- Stock Market
- Insiders
- Francesco Maria Lavino
